APO RESEARCH · REPORT
Neurothrombectomy Devices
A neurothrombectomy device is defined by the Food and Drug Adminstration (FDA) as a device intended to retrieve or destroy blood clots in the cerebral neurovasculature.
Product & engineering
Understand the product.
A neurothrombectomy device is defined by the Food and Drug Adminstration (FDA) as a device intended to retrieve or destroy blood clots in the cerebral neurovasculature.
Selected research
Industry Research
Neurothrombectomy Devices Industry Research Report 2026
Market perspective
A neurothrombectomy device is defined by the Food and Drug Adminstration (FDA) as a device intended to retrieve or destroy blood clots in the cerebral neurovasculature.
In Europe, Neurothrombectomy Devices key players include Stryker, etc. Europe top one manufacturer hold a share over 25%. Germany is the largest market, with a share over 15%.
In terms of product, Retriever is the largest segment, with a share over 90%. And in terms of application, the largest application is Hospitals, followed by Clinics.
Read the full market overview
Report Scope
This report quantifies the global Neurothrombectomy Devices market in revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Neurothrombectomy Devices.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neurothrombectomy Devices Market by Company
Stryker
Medtronic
Penumbra
Phenox
Acandis GmbH
Neurothrombectomy Devices Segment by Type
Retriever
Integrated System
Neurothrombectomy Devices Segment by Application
Hospitals
Clinics
Others
Neurothrombectomy Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurothrombectomy Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurothrombectomy Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurothrombectomy Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Neurothrombectomy Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Neurothrombectomy Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Neurothrombectomy Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Retriever
- Integrated System
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Stryker
- Medtronic
- Penumbra
- Phenox
- Acandis GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Neurothrombectomy Devices by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Retriever
- 2.2.3 Integrated System
- 2.3 Neurothrombectomy Devices by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Neurothrombectomy Devices Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Neurothrombectomy Devices Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Neurothrombectomy Devices Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Neurothrombectomy Devices Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Neurothrombectomy Devices Production by Manufacturers (2021-2026)
- 3.2 Global Neurothrombectomy Devices Production Value by Manufacturers (2021-2026)
- 3.3 Global Neurothrombectomy Devices Average Price by Manufacturers (2021-2026)
- 3.4 Global Neurothrombectomy Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Neurothrombectomy Devices Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Neurothrombectomy Devices Manufacturers, Product Type & Application
- 3.7 Global Neurothrombectomy Devices Manufacturers Established Date
- 3.8 Global Neurothrombectomy Devices Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Stryker
- 4.1.1 Stryker Neurothrombectomy Devices Company Information
- 4.1.2 Stryker Neurothrombectomy Devices Business Overview
- 4.1.3 Stryker Neurothrombectomy Devices Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Stryker Product Portfolio
- 4.1.5 Stryker Recent Developments
- 4.2 Medtronic
- 4.2.1 Medtronic Neurothrombectomy Devices Company Information
- 4.2.2 Medtronic Neurothrombectomy Devices Business Overview
- 4.2.3 Medtronic Neurothrombectomy Devices Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Medtronic Product Portfolio
- 4.2.5 Medtronic Recent Developments
- 4.3 Penumbra
- 4.3.1 Penumbra Neurothrombectomy Devices Company Information
- 4.3.2 Penumbra Neurothrombectomy Devices Business Overview
- 4.3.3 Penumbra Neurothrombectomy Devices Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Penumbra Product Portfolio
- 4.3.5 Penumbra Recent Developments
- 4.4 Phenox
- 4.4.1 Phenox Neurothrombectomy Devices Company Information
- 4.4.2 Phenox Neurothrombectomy Devices Business Overview
- 4.4.3 Phenox Neurothrombectomy Devices Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Phenox Product Portfolio
- 4.4.5 Phenox Recent Developments
- 4.5 Acandis GmbH
- 4.5.1 Acandis GmbH Neurothrombectomy Devices Company Information
- 4.5.2 Acandis GmbH Neurothrombectomy Devices Business Overview
- 4.5.3 Acandis GmbH Neurothrombectomy Devices Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Acandis GmbH Product Portfolio
- 4.5.5 Acandis GmbH Recent Developments
5 Global Neurothrombectomy Devices Production by Region
- 5.1 Global Neurothrombectomy Devices Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Neurothrombectomy Devices Production by Region: 2021-2032
- 5.2.1 Global Neurothrombectomy Devices Production by Region: 2021-2026
- 5.2.2 Global Neurothrombectomy Devices Production Forecast by Region (2027-2032)
- 5.3 Global Neurothrombectomy Devices Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Neurothrombectomy Devices Production Value by Region: 2021-2032
- 5.4.1 Global Neurothrombectomy Devices Production Value by Region: 2021-2026
- 5.4.2 Global Neurothrombectomy Devices Production Value Forecast by Region (2027-2032)
- 5.5 Global Neurothrombectomy Devices Market Price Analysis by Region (2021-2026)
- 5.6 Global Neurothrombectomy Devices Production and Value, YOY Growth
- 5.6.1 North America Neurothrombectomy Devices Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Neurothrombectomy Devices Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Neurothrombectomy Devices Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Neurothrombectomy Devices Production Value Estimates and Forecasts (2021-2032)
6 Global Neurothrombectomy Devices Consumption by Region
- 6.1 Global Neurothrombectomy Devices Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Neurothrombectomy Devices Consumption by Region (2021-2032)
- 6.2.1 Global Neurothrombectomy Devices Consumption by Region: 2021-2026
- 6.2.2 Global Neurothrombectomy Devices Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Neurothrombectomy Devices Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Neurothrombectomy Devices Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Neurothrombectomy Devices Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Neurothrombectomy Devices Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Neurothrombectomy Devices Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Neurothrombectomy Devices Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Neurothrombectomy Devices Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Neurothrombectomy Devices Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Neurothrombectomy Devices Production by Type (2021-2032)
- 7.1.1 Global Neurothrombectomy Devices Production by Type (2021-2032) & (K Units)
- 7.1.2 Global Neurothrombectomy Devices Production Market Share by Type (2021-2032)
- 7.2 Global Neurothrombectomy Devices Production Value by Type (2021-2032)
- 7.2.1 Global Neurothrombectomy Devices Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Neurothrombectomy Devices Production Value Market Share by Type (2021-2032)
- 7.3 Global Neurothrombectomy Devices Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Neurothrombectomy Devices Production by Application (2021-2032)
- 8.1.1 Global Neurothrombectomy Devices Production by Application (2021-2032) & (K Units)
- 8.1.2 Global Neurothrombectomy Devices Production Market Share by Application (2021-2032)
- 8.2 Global Neurothrombectomy Devices Production Value by Application (2021-2032)
- 8.2.1 Global Neurothrombectomy Devices Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Neurothrombectomy Devices Production Value Market Share by Application (2021-2032)
- 8.3 Global Neurothrombectomy Devices Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Neurothrombectomy Devices Value Chain Analysis
- 9.1.1 Neurothrombectomy Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Neurothrombectomy Devices Production Mode & Process
- 9.2 Neurothrombectomy Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Neurothrombectomy Devices Distributors
- 9.2.3 Neurothrombectomy Devices Customers
10 Global Neurothrombectomy Devices Analyzing Market Dynamics
- 10.1 Neurothrombectomy Devices Industry Trends
- 10.2 Neurothrombectomy Devices Industry Drivers
- 10.3 Neurothrombectomy Devices Industry Opportunities and Challenges
- 10.4 Neurothrombectomy Devices Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst